about
Outcomes after endovascular treatment for anterior circulation stroke presenting as wake-up strokes are not different than those with witnessed onset beyond 8 hours.Genetically-defined deficiency of mannose-binding lectin is associated with protection after experimental stroke in mice and outcome in human strokeAntigen-specific immune reactions to ischemic stroke.The outcome of patients with mild stroke improves after treatment with systemic thrombolysis.Risks and benefits of early antithrombotic therapy after thrombolytic treatment in patients with acute strokeInfection after acute ischemic stroke: a manifestation of brain-induced immunodepression.The immunology of acute stroke.Uric Acid Therapy Prevents Early Ischemic Stroke Progression: A Tertiary Analysis of the URICO-ICTUS Trial (Efficacy Study of Combined Treatment With Uric Acid and r-tPA in Acute Ischemic Stroke).Association Between Time to Reperfusion and Outcome Is Primarily Driven by the Time From Imaging to Reperfusion.Mechanical Thrombectomy in and Outside the REVASCAT Trial: Insights From a Concurrent Population-Based Stroke Registry.Uric Acid Therapy Improves Clinical Outcome in Women With Acute Ischemic Stroke.Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation.Antigen Presentation After Stroke.Frequency and outcome of total anterior circulation strokes without intracranial large-vessel occlusion.Access to Endovascular Treatment in Remote Areas: Analysis of the Reperfusion Treatment Registry of Catalonia.Neuroanatomical correlates of stroke-associated infection and stroke-induced immunodepression.Complete reperfusion is required for maximal benefits of mechanical thrombectomy in stroke patients.Thrombectomy within 8 hours after symptom onset in ischemic stroke.Neutrophil recruitment to the brain in mouse and human ischemic stroke.Intravenous thrombolysis or endovascular therapy for acute ischemic stroke associated with cervical internal carotid artery occlusion: the ICARO-3 study.Functional outcome after primary endovascular therapy or IV thrombolysis alone for stroke. An observational, comparative effectiveness study.Monocyte subtypes predict clinical course and prognosis in human stroke.Monocytes are major players in the prognosis and risk of infection after acute stroke.Harms and benefits of lymphocyte subpopulations in patients with acute stroke.Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data.Safety and efficacy of thrombectomy in acute ischaemic stroke (REVASCAT): 1-year follow-up of a randomised open-label trial.Course of matrix metalloproteinase-9 isoforms after the administration of uric acid in patients with acute stroke: a proof-of-concept study.Evaluation of white matter hypodensities on computed tomography in stroke patients using the Fazekas score.Perfusion Deficits and Mismatch in Patients with Acute Lacunar Infarcts Studied with Whole-Brain CT Perfusion.Different Perfusion Patterns in a Patient with Acute Ischemic Stroke.Final infarct volume is a stronger predictor of outcome than recanalization in patients with proximal middle cerebral artery occlusion treated with endovascular therapy.Isolated frontal disequilibrium as presenting form of anti-Hu paraneoplastic encephalomyelitis.Vessel Wall Enhancement and Blood-Cerebrospinal Fluid Barrier Disruption After Mechanical Thrombectomy in Acute Ischemic Stroke.Relevance of blood-brain barrier disruption after endovascular treatment of ischemic stroke: dual-energy computed tomographic study.Stroke-induced immunodepression is a marker of severe brain damage.Excitability of subcortical motor circuits in Go/noGo and forced choice reaction time tasks.Single-center experience of cerebral artery thrombectomy using the TREVO device in 60 patients with acute ischemic stroke.Brain-derived antigens in lymphoid tissue of patients with acute stroke.Letter by Urra et al regarding article, "Autoimmune responses to the brain after stroke are associated with worse outcome".Altered Brain Computed Tomography Perfusion in Patients With Fluctuating Lacunar Syndrome and Normal Magnetic Resonance Imaging.
P50
Q30303082-E22853F2-CA9F-454E-BC87-18B91C5002C0Q33530136-1B327BB0-4448-46BA-896F-9C09AB7FBC56Q33530136-281E7731-A2F7-4DFF-BE6D-1A307B86BFBDQ34171339-7F967FA5-0D1B-4AB8-ADB7-D666A6FE3ADEQ34635173-6A7E2A63-382D-49EE-8B02-C5B79EE3C814Q34948774-61513216-6FFC-47F2-8CEF-6A81269AEDBFQ36719103-F5C8CAE2-599D-4A02-9764-25B91586FFD7Q38016069-CB018674-659E-4F06-80AF-6584FFEE41DBQ38385894-AC7827F0-6DFE-4320-9DF3-9CA51880FC1BQ38395031-E6418B01-7B84-48A7-840B-FCB3A82D0484Q38401318-A5F0067F-3462-4AE6-86A0-7B71A9FC2999Q38408321-F7FF214E-6824-4A99-B9A2-61AE5C80873DQ38834682-F83D9FBB-6B37-4474-BF76-6A551F4FEFEFQ38925065-3EF1E0E9-ED08-4C88-82AC-6AB6EBB2C5E0Q39176940-2FDD69DD-6EAF-4720-B472-DD9E99F030C6Q39874415-90D15705-B7BD-4345-B658-1835BC80AE80Q40506374-44B19AB7-BFD5-4DC4-8363-5772DCBD05C0Q41045620-DC2C52A0-9C83-4C34-BD0A-292134F5D8EFQ41060802-37D2A0A7-F509-483E-9188-0504920F6BF4Q41577006-C4DAFEDA-A580-43A1-B7B2-B44F7D14BA2BQ41752933-118D56AF-6617-417A-B561-522502290281Q44011916-D672E13C-A2BD-418D-BA12-936ADF924CA7Q44698655-37DB77EB-74AC-45F2-97A2-6FD79B390C58Q46150742-7777BB56-28C4-492E-8845-FDC0A5BCD59CQ46488968-4202A6C5-327D-4596-8E91-9CF87CCF3B03Q47218991-D13FDBB4-C142-487A-8308-E448F9DA318DQ47569721-2F028417-AEB3-4A62-9623-7259F250A1E2Q47794204-061BAFC7-9278-4F27-AC9B-31D02DF97AAEQ48205537-C6590342-3CB0-41B1-B226-CB482A66F9EDQ48225976-76135CBE-1D09-4BB3-8C9C-4D55CDAD69A3Q48264417-183D3A73-EEFE-4ABB-82F3-D79373F0EBE1Q48290704-45917989-3B66-4A87-B308-4E68EA1C778AQ48292275-C2B78B5E-494F-433C-956B-A454A61DB85DQ48319279-F1D78DAE-3559-40DA-8740-175C83662A88Q48341506-55815072-CBAB-46A6-8C97-D2833BC5004FQ48368491-71F3EE40-E496-4467-B424-2744D16E7E20Q48448636-1401085A-1D5A-4ADA-B395-B9CEA9C464A6Q48601052-05685B1D-E13F-4E61-8FD8-86735EF3587DQ48685767-5F281AA2-5AE2-45C4-A808-E924932AE293Q48725295-4AC51671-682C-4D6E-8484-9B90098F8ADC
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Xabier Urra
@ast
Xabier Urra
@en
Xabier Urra
@es
Xabier Urra
@nl
Xabier Urra
@sl
type
label
Xabier Urra
@ast
Xabier Urra
@en
Xabier Urra
@es
Xabier Urra
@nl
Xabier Urra
@sl
prefLabel
Xabier Urra
@ast
Xabier Urra
@en
Xabier Urra
@es
Xabier Urra
@nl
Xabier Urra
@sl
P1053
B-7637-2019
P106
P1153
23502447200
P21
P2798
P31
P3835
xabier-urra-nuin
P496
0000-0002-4763-5252